Back
Amicus Therapeutics Stock Price Chart
AI Is Disrupting Marketing—Invest Before April 10!
⏳ Secure Your Stake in AI Marketing Before This Window Closes!
Sell
16
FOLD
Amicus Therapeutics
Last Price:
$7.95
Seasonality Move:
3.6%
7 Day Trial
ALL ACCESS PASS
$
7
Final Days: Should You Invest in This AI Startup Now?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.64 | Sell |
| 20-day SMA: | 8.86 | Sell |
| 50-day SMA: | 9.26 | Sell |
| 200-day SMA: | 10.19 | Sell |
| 8-day EMA: | 8.57 | Sell |
| 20-day EMA: | 8.83 | Sell |
| 50-day EMA: | 9.17 | Sell |
| 200-day EMA: | 10.07 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 30.83 | Sell |
| Chaikin Money Flow: | 560721 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.64 - 9.22) | Sell |
| Bollinger Bands (100): | (8.97 - 10.25) | Sell |
Amicus Therapeutics Technical Analysis
| Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 8.16 while FOLD 8-day simple moving average is 8.64, which is a Sell signal.
-
The stock price of FOLD is 8.16 while Amicus Therapeutics 20-day SMA is 8.86, which makes it a Sell.
-
Amicus Therapeutics 50-day simple moving average is 9.26 while FOLD share price is 8.16, making it a Sell technically.
-
FOLD stock price is 8.16 and Amicus Therapeutics 200-day simple moving average is 10.19, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
16
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $8.16. The Score for FOLD is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.5B
Price in USD:
8.16
Share Volume:
4.8M
Amicus Therapeutics 52-Week Range
52-Week High:
12.65
52-Week Low:
7.97
Sell
16
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 8.16 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 8.16 while FOLD 8-day exponential moving average is 8.57, which is a Sell signal.
-
The stock price of FOLD is 8.16 while Amicus Therapeutics 20-day EMA is 8.83, which makes it a Sell.
-
Amicus Therapeutics 50-day exponential moving average is 9.17 while FOLD share price is 8.16, making it a Sell technically.
-
FOLD stock price is 8.16 and Amicus Therapeutics 200-day simple moving average is 10.07, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.27 per share, and an increase next year of $0.33 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Amicus Therapeutics is a Sell
-
Amicus Therapeutics Relative Strength Index (RSI) is 30.83, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (8.64 - 9.22), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (8.97 - 10.25), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.